Home > Publications database > Clinical and molecular features of primary spinal epidural lymphomas. > print

001     304883
005     20250926115134.0
024 7 _ |a 10.1007/s00277-025-06554-0
|2 doi
024 7 _ |a pmid:40993401
|2 pmid
024 7 _ |a 0939-5555
|2 ISSN
024 7 _ |a 0006-5242
|2 ISSN
024 7 _ |a 1432-0584
|2 ISSN
037 _ _ |a DKFZ-2025-01959
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Adolph, Louisa
|0 0009-0006-4308-2423
|b 0
245 _ _ |a Clinical and molecular features of primary spinal epidural lymphomas.
260 _ _ |a New York
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1758806605_8425
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a Lymphomas confined to the spinal epidural space at initial diagnosis are rare and referred to as primary spinal epidural lymphoma (PSEL). This study presents clinical, histopathological, and molecular insights from 13 PSEL cases, including follicular lymphoma (PSEL-FL, N = 4), extranodal marginal zone lymphoma (PSEL-MZL, N = 3), diffuse large B-cell lymphoma (PSEL-DLBCL, N = 5), and Burkitt lymphoma (PSEL-BL, N = 1). Despite localized presentation at initial diagnosis, PSEL with aggressive histologies demonstrated remarkably unfavorable outcomes, contrasting the highly indolent clinical course observed in indolent PSEL, particularly PSEL-FL. Molecular analysis showed similarities to nodal counterparts and separation by entity. Comparison of PSEL-FL and classic FL revealed activated tumor microenvironment-associated pathways, potentially supporting extranodal lymphoma growth in this rarely affected spinal epidural site.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Clinical aspects
|2 Other
650 _ 7 |a Lymphoma
|2 Other
650 _ 7 |a Molecular analysis
|2 Other
650 _ 7 |a Pathology
|2 Other
650 _ 7 |a Primary spinal epidural lymphoma
|2 Other
700 1 _ |a Stoecklein, Veit M
|0 0000-0001-6206-0621
|b 1
700 1 _ |a Passerini, Verena
|0 0000-0003-4094-1502
|b 2
700 1 _ |a Heide, Michael
|b 3
700 1 _ |a Karschnia, Philipp
|0 0000-0002-1254-5310
|b 4
700 1 _ |a Zausinger, Stefan
|b 5
700 1 _ |a von Baumgarten, Louisa
|0 0000-0002-6634-0927
|b 6
700 1 _ |a von Bergwelt-Baildon, Michael
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Tonn, Jörg Christian
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Stoecklein, Sophia
|0 0000-0003-0325-4674
|b 9
700 1 _ |a Thon, Niklas
|0 0000-0003-0011-5281
|b 10
700 1 _ |a Schichor, Christian
|0 0000-0001-6684-3578
|b 11
700 1 _ |a Rudelius, Martina
|0 0000-0002-7332-4589
|b 12
700 1 _ |a Weigert, Oliver
|0 0000-0002-0987-7373
|b 13
773 _ _ |a 10.1007/s00277-025-06554-0
|0 PERI:(DE-600)1458429-3
|p nn
|t Annals of hematology
|v nn
|y 2025
|x 0939-5555
909 C O |o oai:inrepo02.dkfz.de:304883
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0000-0001-6206-0621
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 0000-0002-1254-5310
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 0000-0002-6634-0927
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 0000-0003-0011-5281
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 0000-0002-0987-7373
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-27
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-27
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANN HEMATOL : 2022
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-27
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21